通过线粒体向增强的NIR辐射触发过热症
Hyo Sung Jung1, Jiyou Han, Jae-Hong Lee
1Department of Chemistry, Korea University , Seoul 136-701, Korea.
Journal of the American Chemical Society
|February 10, 2015
概括
研究人员开发了一种名为Mito-CIO的新型纳米粒子,该纳米粒子针对癌细胞线粒体. 在激光激活后,它有效地增加温度,增强癌细胞死亡,并提供一种新的光热疗法方法.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症研究 癌症研究
背景情况:
- 线粒体易受温度变化的影响.
- 光热疗法提供了一个有前途的癌症治疗途径.
- 准有机体可以提高治疗效果.
研究的目的:
- 开发一种针对线粒体的纳米粒子用于光热疗法.
- 评估Mito-CIO在诱导高热和细胞毒性方面的疗效.
- 研究这种方法在临床前癌症模型中的潜力.
主要方法:
- 基于库马林的光氧化铁纳米颗粒 (Mito-CIO) 的合成与线粒体向.
- 选择性地将Mito-CIO传递给HeLa细胞中的线粒体.
- 接近红外 (740 nm) 激光照射以诱导高热.
- 评估细胞内温度升高和细胞毒性.
- 在瘤异种移植小鼠模型中的验证.
主要成果:
- 米托-CIO成功地准了线粒体.
- 激光照射Mito-CIO处理的细胞在5分钟内使细胞内温度升高2.1°C.
- 与非向纳米颗粒相比,Mito-CIO表现出增强的高温和细胞毒性.
- 在瘤异种移植小鼠模型中证实了有效的结果.
结论:
- Mito-CIO代表了第一个近红外激光激活的,针对线粒体的纳米粒子用于光热疗法.
- 这种有针对性的方法显著提高了癌细胞的细胞毒性.
- 这些发现表明了开发先进光热疗法的有希望的新方向.
更多相关视频
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
3.0K
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.7K
相关概念视频
01:25Increased Body Temperature
7.7K
A body temperature above 38°C (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
7.7K
01:46Electron Transport Chain: Complex I and II
19.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.8K